CNA Financial Corporation research snapshot
CNA AI stock analysis currently reads CNA Financial Corporation as a long-standing U.S. commercial property and casualty insurer with record 2025 core income, a growing investment book, and a visible Q1 2026 underwriting setback from reserve actions and softer accident-year results. At the July 12, 2026 data cutoff, CNA traded near $50.91 with an independently verified market capitalization of about $13.77 billion. Loews Corporation still owns roughly 92% of the company, so free float is thin and liquidity is a structural feature of the stock. This page uses scenarios, technical levels, and source-backed facts. It is informational research, not investment advice.
Current price
$50.91
Market cap
$13.77 billion
AI score
64 / 100
Rating
Solid commercial P&C insurer, underwriting pressure rising
Trend status
Rebound near highs above intermediate moving averages
Data cutoff (updated weekly)
July 12, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | CNA earns mainly by underwriting Specialty, Commercial, and International P&C risks, then investing the float while managing run-off Life & Group and legacy Corporate liabilities. | Medium-high |
| Moat | The moat comes from broker relationships, product expertise, brand history, claims and underwriting data, and balance-sheet strength, including an AM Best financial strength upgrade to A+ in late 2025. Pricing power remains cyclical. | Medium |
| Management | Douglas M. Worman leads as Chairman and CEO, with Scott R. Lindquist as CFO. Capital return has been shareholder-friendly through regular dividends and a 2025 special dividend, while Loews remains the controlling owner. | Medium |
| Financial trend | FY2025 produced record core income of $1.342 billion and net income of $1.278 billion, but Q1 2026 core income fell to $225 million as the P&C combined ratio rose to 102.2%. | High |
| Valuation | At $50.91, CNA traded near 10.9x FY2025 EPS of $4.69, about 1.27x Q1 2026 book value of $40.13, and a roughly 3.8% forward regular dividend yield on the $0.48 quarterly payout. | High |
| Technical trend | As of early July 2026 snapshots, CNA was trading near the top of its 52-week range after rebounding above the 50-day and 200-day averages, with beta near 0.28. | Medium |
| Risk level | Key risks are casualty social inflation, adverse prior-year development, catastrophes, investment marks, run-off long-term care and mass tort, and thin free float under Loews control. | Medium-high |
| AI confidence | High for descriptive filings and verified calculations. Lower for exact stock outcomes because insurance results can change quickly after reserve updates or catastrophe quarters. | High data confidence |
| Investment certainty | Medium certainty. The commercial franchise is durable, but a buy decision depends on price, reserve confidence after Q1 actions, dividend sustainability, and tolerance for controlling-shareholder structure. | Medium |
CNA AI stock forecast
The CNA AI stock forecast uses scenario math around the $50.91 quote and about $4.02 consensus FY2026 EPS. The audited three-year framework produced a bearish area near $31, a base area near $48, and a bullish area near $66 before dividends.
$63 to $68
More likely if core EPS compounds near 8% annually, underlying combined ratios move back below the mid-90s, reserve development stabilizes, investment income stays firm, and investors re-rate the stock toward about 13x earnings.
$46 to $51
More likely if EPS grows near 3% annually, underwriting normalizes after the Q1 2026 reserve action, the regular dividend is maintained, and the market values CNA near 11x earnings close to the current price band.
$28 to $34
More likely if social inflation, further adverse development, catastrophe losses, or weaker investment income cut EPS and the multiple compresses toward about 9x.
CNA AI technical analysis
CNA AI technical analysis is constructive but extended as of the July 12, 2026 cutoff. MarketBeat data around the early July quote showed a 50-day moving average near $45.42 and a 200-day moving average near $46.72, with price trading above both after a rebound toward the $52.86 52-week high area.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $50.91 | Macrotrends close on July 9, 2026, used for market cap and valuation math at the July 12, 2026 cutoff. |
| Near support | $45.42 to $46.72 | The 50-day and 200-day moving average band from early July MarketBeat data is the first intermediate support zone after a pullback from recent highs. |
| Near resistance | $51.80 to $52.86 | Macrotrends showed a July 7, 2026 close of $51.80 as an all-time closing high area, with the 52-week high near $52.86 as the next upside ceiling. |
| 50-day moving average | $45.42 | Price was well above this level in early July, supporting the intermediate rebound unless the average is reclaimed lower. |
| 200-day moving average | $46.72 | Price was above the 200-day average, keeping the longer-term trend constructive unless this level breaks with volume. |
| Momentum | Near 52-week highs after multi-month rebound | Price recovery from the low-$40s area toward $50+ shows positive momentum, but proximity to highs raises failed-breakout risk after weak Q1 underwriting news. |
| Volume | About 0.5 million average daily shares | Morningstar listed average volume near 532,000 shares. Thin free float under Loews ownership can amplify price moves. |
| Volatility | Beta 0.28 | MarketBeat listed a beta near 0.28, so beta understates event risk around reserve, catastrophe, and earnings surprises. |
| Invalidation | Close below $46.72, then $45.42 | A close below the 200-day average would weaken the rebound thesis. A break below the 50-day average would be a deeper short-term warning. |
CNA AI trading strategy
The CNA AI trading strategy is a rules-based research framework for a majority-owned commercial P&C insurer with strong 2025 results, Q1 2026 reserve pressure, and a meaningful dividend. It is not personal advice and should be paired with live quotes, filings, position sizing, and risk controls.
Watch for CNA to hold above the $45.42 to $46.72 moving-average band and clear the $51.80 to $52.86 resistance zone with better than average volume.
A close below $46.72 or a failed breakout after earnings or catastrophe news should invalidate the short-term setup.
If CNA pulls back toward the 200-day average without a new reserve, catastrophe, or dividend shock, compare the reaction with book value, combined ratio, and core ROE.
Do not average down without a defined loss limit because casualty reserve news can reprice the stock quickly and free float is limited.
Track P&C net written premiums, combined ratio, underlying combined ratio, prior-year development, catastrophe points, net investment income, book value ex AOCI, regular dividend coverage, and Life & Group plus Corporate run-off losses.
Reduce confidence if core income relies mainly on investment income while underwriting stays unprofitable, or if reserve strengthening continues for multiple quarters.
Investment research summary
Customers pay CNA to transfer commercial property, casualty, specialty, and professional liability risks. The company earns from underwriting discipline, broker distribution, claims handling, and investment income on insurance float, while run-off Life & Group and legacy liabilities remain non-core overhangs.
The moat is strongest in broker relationships, specialty product knowledge, multi-decade brand presence, underwriting data, and capital strength. It narrows when competitors cut price, social inflation outruns rate, or reserve shortfalls force catch-up charges.
The thesis fails if excess casualty and professional liability reserves keep deteriorating, catastrophes cluster, investment income falls with rates or credit stress, run-off liabilities expand, or Loews-controlled capital policy reduces minority-shareholder optionality.
Worman has emphasized selective growth, expense discipline, and capital return, including a 4% regular dividend increase to $0.48 and a $2.00 special dividend after 2025. Execution now hinges on whether underwriting and reserving regain control after Q1 2026 pressure.
Commercial insurance remains tied to economic activity, asset values, litigation trends, cyber risk, and climate volatility. Pricing cycles still matter: rate gains slowed in Q1 2026, with written rate of about +2% and retention near 83%.
CNA is not priced like a distressed insurer after its rebound toward highs. Margin of safety depends on normalized core EPS after reserve noise, book-value growth ex AOCI, dividend sustainability, and whether investors accept a mid-teens or lower teens multiple for a Loews-controlled P&C franchise.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| CNA price | $50.91 close on July 9, 2026 | Macrotrends stock price history | July 12, 2026 |
| Market capitalization | $13.77 billion, verified as $50.91 x 270.53 million shares | financial_rigor.py market cap verification | July 12, 2026 |
| Shares outstanding | 270.53 million shares (StockAnalysis); Macrotrends Q1 2026 about 272 million | StockAnalysis and Macrotrends cross-check | July 12, 2026 |
| FY2025 net income | $1.278 billion, or $4.69 per diluted share | CNA Financial FY2025 earnings release | July 12, 2026 |
| FY2025 core income | $1.342 billion, or $4.93 per diluted share (record) | CNA Financial FY2025 earnings release | July 12, 2026 |
| FY2025 P&C net written premiums | $10.683 billion, up 5% year over year | CNA Financial FY2025 earnings release | July 12, 2026 |
| FY2025 P&C combined ratio | 94.7% all-in; 91.8% underlying | CNA Financial FY2025 earnings release | July 12, 2026 |
| FY2025 net investment income | $2.557 billion | CNA Financial FY2025 earnings release | July 12, 2026 |
| Q1 2026 earnings | Net income $211 million ($0.78/share); core income $225 million ($0.83/share) | CNA Financial Q1 2026 earnings release | July 12, 2026 |
| Q1 2026 P&C underwriting | Combined ratio 102.2%; underlying combined ratio 94.5%; net written premiums $2.622 billion | CNA Financial Q1 2026 earnings materials | July 12, 2026 |
| Book value per share | $40.13 reported; $45.12 excluding AOCI at March 31, 2026 | CNA Financial Q1 2026 earnings release | July 12, 2026 |
| Dividend | $0.48 quarterly regular dividend; about 3.8% yield at $50.91 | CNA IR dividend history and Q1 2026 declaration | July 12, 2026 |
| Controlling ownership | Loews Corporation owns approximately 92% of CNA | Loews Corporation 2025 year-end financial disclosures | July 12, 2026 |
| Technical snapshot | 50-day MA about $45.42; 200-day MA about $46.72; 52-week range about $41.53 to $52.86 | MarketBeat and Macrotrends technical and range data | July 12, 2026 |
This CNA AI stock analysis is an informational research tool only. It is not investment advice, a recommendation, or a guarantee of future returns. Forecast scenarios are based on available public data as of July 12, 2026 and may be wrong if CNA fundamentals, reserves, catastrophe losses, investment markets, Loews ownership policy, regulation, or market valuation change.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
